Search results
Stock market today: Trump Media shares up, investors watch more earnings
Newsweek· 6 hours agoThe Nasdaq 100, S&P 500 and Dow Jones Industrial Average, all closed marginally up on Monday at...
Donald Trump Slams Bill Maher’s ‘Really Boring’ Interview With ‘LIBERAL’ RFK Jr.: ‘He Has No Hope’
The Wrap via Yahoo News· 2 days agoKennedy, he continues, was thrown out of the Democratic Party “like a dog” The post Donald Trump...
British patients test world’s first personalised MRNA cancer jab for melanoma
The Independent via Yahoo News· 5 days agoThe “gamechanger” jab works by telling the body to hunt down cancer cells to prevent the deadly...
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 2 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
mRNA Is Promising A Breakthrough In Fighting Cancer - Pfizer (NYSE:PFE)
Benzinga· 1 day agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered....
New studies point to safety of COVID vaccines, but leave questions unanswered
KARE 11 Minneapolis-St. Paul· 6 days agoAfter more than 13 billion COVID vaccines given around the world, the largest studies to date point...
Bill Maher Batters His Buddy RFK Jr. Over Anti-Vax Claims
The Daily Beast via Yahoo News· 3 days agoHBOBill Maher took presidential candidate Robert F. Kennedy Jr. to task on Friday’s episode of Real...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 1 hour agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 7 days agoThe most recent mRNA failure was a phase 1 trial of Moderna’s mRNA human immunodeficiency virus (HIV) injection. "We are taking this very seriously," Carl Dieffenbach, head ...